The discovery of cancer-associated fibroblasts (CAFs) in the GB TME and the expression of FAP in both GB cells and non-malignant stromal cells within the TME, makes FAP an attractive target for radiopharmaceuticals 192,193. The gene discussed is FAP; the disease is cancer.